These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 29252093

  • 1. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
    Hakamata J, Hashiguchi M, Kaneko Y, Yamaoka K, Shimizu M, Maruyama J, Takeuchi T, Mochizuki M.
    Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R, Chonprasertsuk S, Siramolpiwat S.
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [Abstract] [Full Text] [Related]

  • 4. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Amital H, Arnson Y, Chodick G, Shalev V.
    Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of C35T polymorphism in dihydrofolate reductase gene with toxicity of methotrexate in rheumatoid arthritis patients.
    Vejnović D, Milić V, Popović B, Damnjanović T, Maksimović N, Bunjevački V, Krajinović M, Novaković I, Damjanov N, Jekić B.
    Expert Opin Drug Metab Toxicol; 2019 Mar; 15(3):253-257. PubMed ID: 30583708
    [Abstract] [Full Text] [Related]

  • 7. ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.
    Muralidharan N, Mariaselvam CM, Jain VK, Gulati R, Negi VS.
    Pharmacogenomics; 2016 Feb; 17(3):241-8. PubMed ID: 26799664
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.
    Kooloos WM, Wessels JA, van der Straaten T, Allaart CF, Huizinga TW, Guchelaar HJ.
    Pharmacogenomics; 2010 Feb; 11(2):163-75. PubMed ID: 20136356
    [Abstract] [Full Text] [Related]

  • 10. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    Mori S, Arima N, Ito M, Fujiyama S, Kamo Y, Ueki Y.
    PLoS One; 2018 Feb; 13(8):e0203084. PubMed ID: 30142184
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.
    Takatori R, Takahashi KA, Tokunaga D, Hojo T, Fujioka M, Asano T, Hirata T, Kawahito Y, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo T.
    Clin Exp Rheumatol; 2006 Feb; 24(5):546-54. PubMed ID: 17181924
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.
    Wessels JA, Kooloos WM, De Jonge R, De Vries-Bouwstra JK, Allaart CF, Linssen A, Collee G, De Sonnaville P, Lindemans J, Huizinga TW, Guchelaar HJ.
    Arthritis Rheum; 2006 Sep; 54(9):2830-9. PubMed ID: 16947783
    [Abstract] [Full Text] [Related]

  • 15. Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
    de Rotte MCFJ, Pluijm SMF, de Jong PHP, Bulatović Ćalasan M, Wulffraat NM, Weel AEAM, Lindemans J, Hazes JMW, de Jonge R.
    PLoS One; 2018 Sep; 13(12):e0208534. PubMed ID: 30532219
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
    Qiu Q, Huang J, Shu X, Fan H, Zhou Y, Xiao C.
    Sci Rep; 2017 Mar 07; 7():44015. PubMed ID: 28266606
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
    Lee YH, Bae SC.
    Rheumatol Int; 2016 Nov 07; 36(11):1591-1599. PubMed ID: 27379764
    [Abstract] [Full Text] [Related]

  • 19. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H, Ohno S, Ishigatsubo Y.
    J Clin Rheumatol; 2007 Apr 07; 13(2):73-8. PubMed ID: 17414533
    [Abstract] [Full Text] [Related]

  • 20. No correlation between MTHFR c.677 C > T, MTHFR c.1298 A > C, and ABCB1 c.3435 C > T polymorphisms and methotrexate therapeutic outcome of rheumatoid arthritis in West Algerian population.
    Boughrara W, Benzaoui A, Aberkane M, Moghtit FZ, Dorgham S, Lardjam-Hetraf AS, Ouhaibi-Djellouli H, Teixeira EP, Boudjema A.
    Inflamm Res; 2017 Jun 07; 66(6):505-513. PubMed ID: 28299396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.